Irritability and risk of lung cancer: a Mendelian randomization and mediation analysis

[11] Bryant RA(2016)Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study PeerJ 19 e1003859-1061

[12] Malhi GS(2022)The relationship between lipoprotein A and other lipids with prostate cancer risk: a multivariable Mendelian randomisation study PLoS Med 9 107-1579

[13] Budisan L(2020)Irritability in Huntington’s disease JHD 81 144-48

[14] Zanoaga O(2022)Causal associations between gastroesophageal reflux disease and lung cancer risk: a Mendelian randomization study Cancer Med 77 45-146

[15] Braicu C(2021)Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy Can Res 72 144-698

[16] Burgess S(2021)Diet-derived circulating antioxidants and risk of coronary heart disease J Am Coll Cardiol 32 S69-1499

[17] Butterworth A(2022)Integrative oncology: addressing the global challenges of cancer prevention and treatment CA Cancer J Clin 22 8661-2030

[18] Thompson SG(2012)Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models: lung cancer in never smokers Risk Anal 71 1053-1441

[19] Cain DW(2021)Current and future development in lung cancer diagnosis IJMS 14 e0222362-1010

[20] Cidlowski JA(2022)Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis Gut 11 a038984-14.e1

[11] Bryant RA(2016)Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study PeerJ 19 e1003859-1061

[12] Malhi GS(2022)The relationship between lipoprotein A and other lipids with prostate cancer risk: a multivariable Mendelian randomisation study PLoS Med 9 107-1579

[13] Budisan L(2020)Irritability in Huntington’s disease JHD 81 144-48

[14] Zanoaga O(2022)Causal associations between gastroesophageal reflux disease and lung cancer risk: a Mendelian randomization study Cancer Med 77 45-146

[15] Braicu C(2021)Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy Can Res 72 144-698

[16] Burgess S(2021)Diet-derived circulating antioxidants and risk of coronary heart disease J Am Coll Cardiol 32 S69-1499

[17] Butterworth A(2022)Integrative oncology: addressing the global challenges of cancer prevention and treatment CA Cancer J Clin 22 8661-2030

[18] Thompson SG(2012)Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models: lung cancer in never smokers Risk Anal 71 1053-1441

[19] Cain DW(2021)Current and future development in lung cancer diagnosis IJMS 14 e0222362-1010

[20] Cidlowski JA(2022)Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis Gut 11 a038984-14.e1